Literature DB >> 19005743

Approximations of the target-mediated drug disposition model and identifiability of model parameters.

Leonid Gibiansky1, Ekaterina Gibiansky, Tarundeep Kakkar, Peiming Ma.   

Abstract

Models for drugs exhibiting target-mediated drug disposition (TMDD) play an important role in the investigation of biological products (Mager and Jusko 2001). These models are often overparameterized and difficult to converge. A simpler quasi-equilibrium (QE) approximation of the general model has been suggested (Mager and Krzyzanski 2005), but even this simpler form can be overparameterized when, for example, drug target level is not available. This work (a) introduces quasi-steady-state (QSS) and Michaelis-Menten (MM) approximations of the TMDD model, (b) derives the relationships between the parameters of the TMDD, QE, QSS and MM models, (c) investigates the parameter ranges where the simplified approximations are equivalent to the TMDD model, (d) proposes an algorithm for establishing identifiability of these models, and (e) tests this algorithm on simulated datasets. The proposed QSS approximation is more general than the QE approximation: it degenerates into the QE approximation when the internalization rate of the drug-target complex is much smaller than its dissociation rate. The proposed identifiability analysis algorithm may be applied to provide justification for use of simplified approximations, avoiding use of incorrect parameter estimates of over-parameterized TMDD models while simultaneously saving time and resources required for the pharmacokinetics analysis of drugs with TMDD. The utility of the derived approximations and of the identifiability algorithm was demonstrated on the examples of the simulated data sets. The simulation examples indicated that the QSS model may be preferable to the QE model when the internalization rate of the drug-target complex significantly exceeds its dissociation rate. The MM approximation may be adequate when the drug concentration significantly exceeds the target concentrations or when the target occupancy is close to 100%.

Mesh:

Substances:

Year:  2008        PMID: 19005743     DOI: 10.1007/s10928-008-9102-8

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  3 in total

1.  General pharmacokinetic model for drugs exhibiting target-mediated drug disposition.

Authors:  D E Mager; W J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2001-12       Impact factor: 2.745

2.  Quasi-equilibrium pharmacokinetic model for drugs exhibiting target-mediated drug disposition.

Authors:  Donald E Mager; Wojciech Krzyzanski
Journal:  Pharm Res       Date:  2005-09-22       Impact factor: 4.200

3.  A mechanism-based binding model for the population pharmacokinetics and pharmacodynamics of omalizumab.

Authors:  Naoto Hayashi; Yuko Tsukamoto; William M Sallas; Philip J Lowe
Journal:  Br J Clin Pharmacol       Date:  2006-11-10       Impact factor: 4.335

  3 in total
  116 in total

1.  Dose correction for the Michaelis-Menten approximation of the target-mediated drug disposition model.

Authors:  Xiaoyu Yan; Wojciech Krzyzanski
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-01-04       Impact factor: 2.745

2.  Population pharmacokinetic/pharmacodynamic analyses as the basis for dosing of therapeutic monoclonal antibodies.

Authors:  Bernd Meibohm
Journal:  Clin Pharmacokinet       Date:  2011-12-01       Impact factor: 6.447

3.  Theoretical considerations of target-mediated drug disposition models: simplifications and approximations.

Authors:  Peiming Ma
Journal:  Pharm Res       Date:  2011-12-01       Impact factor: 4.200

4.  Comparison of Nonmem 7.2 estimation methods and parallel processing efficiency on a target-mediated drug disposition model.

Authors:  Leonid Gibiansky; Ekaterina Gibiansky; Robert Bauer
Journal:  J Pharmacokinet Pharmacodyn       Date:  2011-11-19       Impact factor: 2.745

Review 5.  Population pharmacokinetics of therapeutic monoclonal antibodies.

Authors:  Nathanael L Dirks; Bernd Meibohm
Journal:  Clin Pharmacokinet       Date:  2010-10       Impact factor: 6.447

6.  Target-mediated drug disposition model for drugs that bind to more than one target.

Authors:  Leonid Gibiansky; Ekaterina Gibiansky
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-07-29       Impact factor: 2.745

7.  Mechanistic Modeling of the Pharmacodynamic and Pharmacokinetic Relationship of Tissue Factor Pathway Inhibitor-Neutralizing Antibody (BAY 1093884) in Cynomolgus Monkeys.

Authors:  Jian-Ming Gu; Xiao-Yan Zhao; Thomas Schwarz; Joachim Schuhmacher; Andreas Baumann; Elena Ho; Babu Subramanyan; Kathy Tran; Timothy Myles; Chandra Patel; Maria Koellnberger
Journal:  AAPS J       Date:  2017-05-17       Impact factor: 4.009

8.  Target-mediated drug disposition model and its approximations for antibody-drug conjugates.

Authors:  Leonid Gibiansky; Ekaterina Gibiansky
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-12-11       Impact factor: 2.745

9.  Impact of altered endogenous IgG on unspecific mAb clearance.

Authors:  Saskia Fuhrmann; Charlotte Kloft; Wilhelm Huisinga
Journal:  J Pharmacokinet Pharmacodyn       Date:  2017-04-24       Impact factor: 2.745

10.  Selection between Michaelis-Menten and target-mediated drug disposition pharmacokinetic models.

Authors:  Xiaoyu Yan; Donald E Mager; Wojciech Krzyzanski
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-12-10       Impact factor: 2.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.